Therefore, the identification of novel biomarkers associated with CD4+ T-cell infiltration may contribute to the exploration of the immune infiltration mechanism of DM, and plays an important guiding role for the early diagnosis, the evaluation of prognosis, and the discovery of new therapeutic targets of DM, especially for DM with skin lesions. The gene discussed is CD4; the disease is dermatomyositis.